Company intelligence / Profile preview

Paradigm Health

Columbus, Ohio, United Statesparadigm.inc ↗

Ownership: Private
Development stage: Commercial

Overview

Paradigm Health’s technology has demonstrated significant improvements in trial enrollment efficiency. For example, Highlands Oncology increased patient enrollment by 45% over two years using the platform while reducing research department burden. The company’s partnerships aim to modernize global access to clinical research—recently expanding into Japan with Fujitsu to address “drug loss” issues there.

Therapeutic areas: Other
Modalities: small moleculesbiologicscell/gene therapies
Industry: Contract Research Organization

Partnerships

Bristol Myers SquibbFujitsuSheba Medical Center & ARC Innovation

Beyond the preview

Go deeper on Paradigm Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paradigm Health.

Explore the full profile